Afuco™ Anti-Human IAPP ADCC Therapeutic Antibody (NI-203), ADCC Enhanced
Anti-IAPP ADCC Enhanced Antibody (NI-203) is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specific for IAPP are used for the treatment and diagnosis of diseases from the group of Diabetes mellitus diseases, comprising type 1 diabetes (T1D), gestational diabetes, pre-diabetes, latent autoimmune diabetes of adults (LAD A; type 1, 5 diabetes) and/or type 2 diabetes (T2D).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-360CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IAPP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |